Loading provider…
Loading provider…
Ophthalmic Plastic and Reconstructive Surgery Physician in Stanford, CA
NPI: 1285884106Primary Practice Location
STANFORD HEALTH CARE
300 Pasteur Dr, Stanford, CA
Primary Employer
Stanford Hospital
stanfordhealthcare.org
HQ Phone
Get MD Andrea's Phone Numberphone_androidMobile
Get MD Andrea's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
CA State Medical License
CA State Medical License
2012 - 2025
FL State Medical License
2010 - 2014

American Board of Ophthalmology
Ophthalmology
University of Miami Hospital and Clinics
Fellowship • Ophthalmic Plastic and Reconstructive Surgery
2010 - 2012
Georgetown University School Of Medicine
som.georgetown.edu
Medical School
Until 2006
University of Miami/Jackson Health System/Bascom Palmer Eye Institute
Residency • Ophthalmology
2007 - 2010
Mount Sinai Medical Center of Florida
Internship • Internal Medicine
2006 - 2007
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92285Photography of content of eyes | 214 | 245 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 145 | 162 |
| 3 | 92083Measurement of field of vision during daylight conditions | 104 | 120 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 52 | 56 |
| 5 | 99204New patient office or other outpatient visit, 45-59 minutes | 48 | 48 |
Avelumab as an Emerging Therapy for Eyelid and Periocular Merkel Cell Carcinoma.
Authors: Garcia, Giancarlo A, Kossler, Andrea L
Journal: Int Ophthalmol Clin
Global Rating Assessment of Skills in Intraocular Surgery (GRASIS).
Authors: Cremers, Sandra Lora, Lora, Andrea Nereida, Ferrufino-Ponce, Zandra Karina
Journal: Ophthalmology
Lead Sponsor: Sling Therapeutics, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Linsitinib
Lead Sponsor: Viridian Therapeutics, Inc.
Intervention / Treatment: DRUG: VRDN-001 Placebo, DRUG: VRDN-001 Phase 3 Cohort (THRIVE)
Lead Sponsor: Amgen
Intervention / Treatment: DRUG: Placebo, DRUG: Teprotumumab